191 related articles for article (PubMed ID: 30306802)
1. Transdermal delivery system of nanostructured lipid carriers loaded with Celastrol and Indomethacin: optimization, characterization and efficacy evaluation for rheumatoid arthritis.
Kang Q; Liu J; Zhao Y; Liu X; Liu XY; Wang YJ; Mo NL; Wu Q
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S585-S597. PubMed ID: 30306802
[TBL] [Abstract][Full Text] [Related]
2. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
Gu Y; Tang X; Yang M; Yang D; Liu J
Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
Fan X; Chen J; Shen Q
Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
[TBL] [Abstract][Full Text] [Related]
6. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery.
Song J; Fan X; Shen Q
Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.
Ali Z; Din FU; Zahid F; Sohail S; Imran B; Khan S; Malik M; Zeb A; Khan GM
BMC Pharmacol Toxicol; 2022 Nov; 23(1):86. PubMed ID: 36443818
[TBL] [Abstract][Full Text] [Related]
8. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
[TBL] [Abstract][Full Text] [Related]
9. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
10. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
[No Abstract] [Full Text] [Related]
11. Downregulation of pro-inflammatory markers IL-6 and TNF-α in rheumatoid arthritis using nano-lipidic carriers of a quinone-based phenolic: an in vitro and in vivo study.
Pal RR; Rajpal V; Singh N; Singh S; Mishra N; Singh P; Maurya P; Alka ; Saraf SA
Drug Deliv Transl Res; 2023 Feb; 13(2):627-641. PubMed ID: 35963927
[TBL] [Abstract][Full Text] [Related]
12. Microneedle-mediated transdermal delivery of nanostructured lipid carriers for alkaloids from Aconitum sinomontanum.
Guo T; Zhang Y; Li Z; Zhao J; Feng N
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1541-1551. PubMed ID: 28899209
[TBL] [Abstract][Full Text] [Related]
13. Cubic and hexagonal liquid crystals as drug carriers for the transdermal delivery of triptolide.
Shan QQ; Jiang XJ; Wang FY; Shu ZX; Gui SY
Drug Deliv; 2019 Dec; 26(1):490-498. PubMed ID: 31081409
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
Yue Y; Zhao D; Yin Q
Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
[TBL] [Abstract][Full Text] [Related]
15. Nanotransethosomes for enhanced transdermal delivery of mangiferin against rheumatoid arthritis: formulation, characterization, invivo pharmacokinetic and pharmacodynamic evaluation.
Adin SN; Gupta I; Rashid MA; Alhamhoom Y; Aqil M; Mujeeb M
Drug Deliv; 2023 Dec; 30(1):2173338. PubMed ID: 36729134
[TBL] [Abstract][Full Text] [Related]
16. Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.
Sadarani B; Majumdar A; Paradkar S; Mathur A; Sachdev S; Mohanty B; Chaudhari P
Biomed Pharmacother; 2019 Jun; 114():108770. PubMed ID: 30913494
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
Wang Y; Wang S; Shi P
Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
[TBL] [Abstract][Full Text] [Related]
18. Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis.
Zewail M; Nafee N; Helmy MW; Boraie N
Int J Pharm; 2019 Aug; 567():118447. PubMed ID: 31226475
[TBL] [Abstract][Full Text] [Related]
19. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.
Zhou L; Chen Y; Zhang Z; He J; Du M; Wu Q
Pharmazie; 2012 Apr; 67(4):304-10. PubMed ID: 22570936
[TBL] [Abstract][Full Text] [Related]
20. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]